Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › IDYA
DEERFIELD MANAGEMENT COMPANY, L.P. position in IDYA
IDEAYA BIOSCIENCES INC · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 2,714,503 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$101.2M, representing 1.27% of its reported portfolio and ranking #24 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IDYA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s IDYA position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in IDYA in Q3 2023 at 2,268,628 shares (US$61.2M). The position peaked in Q1 2024 at 2,630,292 shares, worth US$115.4M. Across 12 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,714,503 shares valued at US$101.2M — an increase of 1,184,495 shares quarter over quarter.. Notable position changes include a 45% trim in Q3 2025 (shares rose 27% over the following quarter), a 29% trim in Q1 2026 (shares rose 12% over the following quarter), a 77% increase in Q2 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.27M | $61.21M | New |
| Q4 2023 | 2.63M | $93.59M | Add |
| Q1 2024 | 2.63M | $115.42M | Hold |
| Q2 2024 | 2.10M | $73.63M | Reduce |
| Q3 2024 | 2.59M | $82.18M | Add |
| Q4 2024 | 2.74M | $70.32M | Add |
| Q1 2025 | 3.27M | $53.52M | Add |
| Q2 2025 | 3.92M | $82.30M | Add |
| Q3 2025 | 2.15M | $58.58M | Reduce |
| Q4 2025 | 2.15M | $74.43M | Hold |
| Q1 2026 | 1.53M | $50.98M | Reduce |
| Q2 2026 | 2.71M | $101.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IDYA and 13F data
IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 38 other funds we track also report a position in IDYA — the largest reported positions include BAKER BROS. ADVISORS LP (US$186.7M), Logos Global Management LP (US$111.8M), GSK plc (US$49.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IDYA
- BAKER BROS. ADVISORS LP 5.01M sh · $186.72M · Q2 2026
- Logos Global Management LP 3.00M sh · $111.81M · Q2 2026
- GSK plc 1.33M sh · $49.69M · Q2 2026
- Sofinnova Investments, Inc. 925.12K sh · $34.48M · Q2 2026
- Redmile Group, LLC 640.20K sh · $23.86M · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held IDYA?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IDYA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in IDYA?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 2.71M shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $101.17M, representing 1.27% of its reported portfolio and ranking #24.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling IDYA?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in IDYA. The position peaked in Q1 2024 at 2.63M shares.
Which other funds hold IDYA?
Other major institutional holders of IDYA include BAKER BROS. ADVISORS LP, Logos Global Management LP, GSK plc, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.